Please use this identifier to cite or link to this item:
http://hdl.handle.net/1942/23294
Title: | The Next Generation of Biomarker Research in Spinal Cord Injury | Authors: | YDENS, Elke PALMERS, Ilse HENDRIX, Sven SOMERS, Veerle |
Issue Date: | 2017 | Source: | Molecular neurobiology, 54 (2), p. 1482-1499 | Abstract: | In traumatic spinal cord injury (SCI) patients, the assessment of the exact degree of lesion severity and neurological prognosis has proven to be extremely challenging. The current tools for predicting functional outcome in SCI patients such as clinical examination and magnetic resonance imaging are often inaccessible to unstable or polytraumatized patients, lack sensitivity and are unreliable in the acute phase of the injury. Multiple candidate protein biomarkers known to be linked to the pathology have been studied for their potential to predict neurological outcome over time. This hypothesis-driven approach however, has yielded only minimal success and the reported individual markers lack sensitivity and correlation with specific outcome measures, which highlights the need for an unbiased high-throughput screening approach to identify novel candidate biomarkers. Antibodies were suggested to represent better biomarkers as their counterpart antigens as they are highly specific and abundantly present in blood due to their inherent amplification and long half-life. Moreover, antibodies are easily accessible, and are amenable to high-throughput screening. We therefore suggest an unbiased, high-throughput and powerful antibody profiling procedure, named Serological antigen selection, based on cDNA phage display to combine the multiple benefits of stable and frequent antibodies and those of an unbiased method. The application of such an innovative and unbiased approach can complement the more traditional approaches to aid in the discovery of novel SCI-associated biomarkers. | Notes: | Somers, V (reprint author), Hasselt Univ, Biomed Res Inst, Martelarenlaan 42, B-3500 Diepenbeek, Hasselt, Belgium. veerle.somers@uhasselt.be | Keywords: | antibody; biomarker; patient; serum | Document URI: | http://hdl.handle.net/1942/23294 | ISSN: | 0893-7648 | e-ISSN: | 1559-1182 | DOI: | 10.1007/s12035-016-9757-x | ISI #: | 000394964100056 | Rights: | (C) Springer Science+Business Media New York 2016 | Category: | A1 | Type: | Journal Contribution | Validations: | ecoom 2018 |
Appears in Collections: | Research publications |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
Ydens E, et al. 2017.pdf Restricted Access | Published version | 1.28 MB | Adobe PDF | View/Open Request a copy |
20160120 Review_Ydens et al_revision.pdf | Peer-reviewed author version | 596.11 kB | Adobe PDF | View/Open |
SCOPUSTM
Citations
11
checked on Sep 3, 2020
WEB OF SCIENCETM
Citations
16
checked on Oct 13, 2024
Page view(s)
60
checked on Sep 7, 2022
Download(s)
338
checked on Sep 7, 2022
Google ScholarTM
Check
Altmetric
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.